Robert Nordon

Hidden translation costs in cell and gene therapy manufacturing

Ex vivo cell and gene therapies have demonstrated remarkable clinical efficacy, yet their widespread adoption remains constrained by the complexity and cost of translation and manufacture. Current development commonly progresses through different equipment architectures: standard...